KARYOPHARM THERAPEUTICS INC (KPTI) Institutional Ownership and Insiders Activity
KARYOPHARM THERAPEUTICS INC (KPTI) is widely held by institutional investors, with 100 firms reporting positions valued at approximately $198.94M based on SEC Form 13F filings for the quarter ended June 30, 2026.
Ra Capital Management, L.P. is the largest disclosed holder, reporting approximately $18.73M in KPTI holdings in its latest filing.
Recent insider activity includes 6 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
100
Total Reported Value
$198.94M
Largest Holder
Ra Capital Management, L.P.
Largest Position
$18.73M
Insider Transactions (90d)
6
Latest Filing Quarter
Q2 2026
New Institutional Positions
36
Funds Exiting Positions
14
Top Institutional Owners
View allInvestorReported Balance
- Ra Capital Management, L.P.$18.73M
- Adage Capital Partners Gp, L.L.C.$14.86M
- Acorn Capital Advisors, Llc$14.83M
- Goldman Sachs Group Inc$13.92M
- Blackrock, Inc.$13.86M
Related KPTI Institutional Insights:
- KPTI 13F Institutional Holders
- KPTI Superinvestors
- KPTI Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- KPTI Insider Trading & SEC Form 4 Activity
- KPTI Articles
- Top Institutional Investor Stock Rankings